scout
Opinion|Videos|December 8, 2023

EMERALD Subgroup Analysis in Patients with Coexisting PIK3CA and TP53 Mutations

Dr. Hope Rugo discusses EMERALD subgroup analysis, safety, and efficacy in patients with coexisting resistance mutations.

Newsletter

Stay up to date on practice-changing data in community practice.


Latest CME